Bayer Company News
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the latest items in this publication.
195 records returned
Bayer strengthens sustainability commitment
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Focus on the fields of health care, nutrition and climate protection / Eight lighthouse projects: More than 15 million people benefit directly / New technologies to reduce greenhouse gas emissions by five million metric tons per year / Management Board Chairman Wenning: “We are making specific contributions to balance commercial success with the protection of the environment and the needs of society” (Source: Bayer Company News)
Source: Bayer Company News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Bayer CropScience completes acquisition of biotech company Athenix Corp.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Purchase price of USD 365 million plus milestones (Source: Bayer Company News)
Source: Bayer Company News - November 2, 2009 Category: Pharmaceuticals Source Type: news
Bayer back on the uptrendEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
HealthCare again strong – weak quarter at CropScience – MaterialScience substantially improved / Group sales EUR 7,392 million (minus 7.0 percent) / EBITDA before special items EUR 1,499 million (plus 0.4 percent) / Net income EUR 249 million (minus 10.1 percent) / Net cash flow EUR 1,517 million (plus 22.9 percent) / Full-year Group forecast confirmed (Source: Bayer Company News)
Source: Bayer Company News - October 27, 2009 Category: Pharmaceuticals Source Type: news
Bayer Early Excellence in Science Award 2009: EUR 30,000 for young research scientistsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Dr. Jürgen Groll (RWTH Aachen) awarded prize in the “Materials” field / Dr. Noriyuki Nishimura (University of California, San Diego, United States) honored in the “Biology” category / Dr. Tobias Ritter (Harvard University, United States) winner of the award for “Chemistry” (Source: Bayer Company News)
Source: Bayer Company News - October 23, 2009 Category: Pharmaceuticals Source Type: news
The risk of venous thromboembolism for drospirenone containing oral contraceptives is comparable to the risk of other oral contraceptives available on the marketEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - October 22, 2009 Category: Pharmaceuticals Source Type: news
Bayer MaterialScience AG ends reduced working hours at German sitesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - October 9, 2009 Category: Pharmaceuticals Source Type: news
Bayer CropScience first to sequence the entire genome of rapeseed/canolaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - October 9, 2009 Category: Pharmaceuticals Source Type: news
Nexavar® in Combination with Chemotherapy Demonstrates 74 Percent Improvement in Progression-Free SurvivalEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - September 23, 2009 Category: Pharmaceuticals Source Type: news
Bayer researchers nominated for the “Deutscher Zukunftspreis” awarded by the German Federal PresidentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - September 22, 2009 Category: Pharmaceuticals Source Type: news
Bayer honored as world’s best company in climate protectionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - September 22, 2009 Category: Pharmaceuticals Source Type: news
Bayer’s Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer PatientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - September 22, 2009 Category: Pharmaceuticals Source Type: news
Bayer CropScience accelerates expansion of biotech and seed business with investments of around EUR 3.5 billion through 2018Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - September 17, 2009 Category: Pharmaceuticals Source Type: news
Dr. Marijn E. Dekkers to be new CEO of Bayer from October 1, 2010Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - September 15, 2009 Category: Pharmaceuticals Source Type: news
Bayer remains “best in class” in sustainabilityEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - September 4, 2009 Category: Pharmaceuticals Source Type: news
Bayer and Algeta Enter Global Agreement for Development and Commercialization of Treatment for Bone Metastases in Cancer PatientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - September 3, 2009 Category: Pharmaceuticals Source Type: news
Bayer Acquires Two Prescription Dermatology Product Lines from SkinMedica in the U.S.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - September 2, 2009 Category: Pharmaceuticals Source Type: news
Bayer Completes Enrollment into Major Phase III Study with Rivaroxaban (ROCKET AF)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - August 30, 2009 Category: Pharmaceuticals Source Type: news
Children’s pictures challenge climate changeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - August 20, 2009 Category: Pharmaceuticals Source Type: news
Bayer CropScience acquires US biotech company Athenix Corp.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - August 19, 2009 Category: Pharmaceuticals Source Type: news
New Levitra® formulation submitted for registration in the EUEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - August 19, 2009 Category: Pharmaceuticals Source Type: news
Bayer robust in a difficult environmentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - July 29, 2009 Category: Pharmaceuticals Source Type: news
Nexavar® in Combination with Chemotherapy Shown To Extend Progression-Free Survival in Patients with Advanced Breast CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - July 22, 2009 Category: Pharmaceuticals Source Type: news
Bayer CropScience expands global R&D activities in seeds and traits by setting up new research focus area in cerealsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - July 21, 2009 Category: Pharmaceuticals Source Type: news
Bayer CropScience expands global R&D activities in seeds and traits by setting up new research focus area in cerealsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - July 21, 2009 Category: Pharmaceuticals Source Type: news
Bayer MaterialScience lifts force majeure for TDI in EuropeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - July 16, 2009 Category: Pharmaceuticals Source Type: news
Bayer presents positive Phase II data with florbetabenEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - July 13, 2009 Category: Pharmaceuticals Source Type: news
Bayer acquires exclusive rights to Bioton’s insulin SciLin®Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - July 9, 2009 Category: Pharmaceuticals Source Type: news
Bayer submits first-in-class estradiol-based oral contraceptive for approval in the U.S.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - July 8, 2009 Category: Pharmaceuticals Source Type: news
Bayer MaterialScience declares force majeure for TDI in EuropeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - July 7, 2009 Category: Pharmaceuticals Source Type: news
Bayer files patent infringement lawsuit against TevaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - July 1, 2009 Category: Pharmaceuticals Source Type: news
Bayer CropScience and Monsanto sign cross licensing agreement on herbicide tolerance traits in rapeseed/canolaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - June 29, 2009 Category: Pharmaceuticals Source Type: news
Bayer CropScience and DuPont expand collaboration with broad license agreementsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - June 25, 2009 Category: Pharmaceuticals Source Type: news
Bayer Technology Services completed sulfuric acid plant featuring innovative technologyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - June 16, 2009 Category: Pharmaceuticals Source Type: news
Bayer HealthCare and Genzyme Finalize Strategic Alliance AgreementEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - June 2, 2009 Category: Pharmaceuticals Source Type: news
Bayer and Onyx Initiate Phase III Trial of Nexavar® in Non-small Cell Lung CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - June 1, 2009 Category: Pharmaceuticals Source Type: news
Bayer Schering Pharma Announces New Data on Novel Anti-cancer Compound BAY 73-4506Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - May 30, 2009 Category: Pharmaceuticals Source Type: news
U.S. FDA Issues Complete Response Letter for RivaroxabanEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - May 28, 2009 Category: Pharmaceuticals Source Type: news
Phase III Trial Started to Evaluate Combination Therapy of Nexavar® and Tarceva® in Patients with Liver CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - May 28, 2009 Category: Pharmaceuticals Source Type: news
Bayer: Successful and sustainable businessEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - May 26, 2009 Category: Pharmaceuticals Source Type: news
U.S. Department of Agriculture grants approval for Bayer CropScience’s GlyTol™ cotton technologyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - May 22, 2009 Category: Pharmaceuticals Source Type: news
Nexavar® Approved in Japan for the Treatment of Advanced Liver CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - May 20, 2009 Category: Pharmaceuticals Source Type: news
Bayer Schering Pharma presents positive results of phase II study with RiociguatEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - May 19, 2009 Category: Pharmaceuticals Source Type: news
Qlaira® – innovative estradiol-based oral contraceptive available in Europe from May onwardsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - May 14, 2009 Category: Pharmaceuticals Source Type: news
“Corporate strategy proves effective in a difficult environment”Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - May 12, 2009 Category: Pharmaceuticals Source Type: news
Bayer Schering Pharma is starting Phase III studies with an innovative low-dose contraceptive patchEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - May 5, 2009 Category: Pharmaceuticals Source Type: news
Bayer and Regeneron extend development program for VEGF Trap-EyeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - April 30, 2009 Category: Pharmaceuticals Source Type: news
CropScience and Pharmaceuticals continue on a path of growth – Slump in business at MaterialScience leaves a distinct markEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - April 29, 2009 Category: Pharmaceuticals Source Type: news
Bayer and Ardea Biosciences Enter Global Agreement Focused on the Development of MEK Inhibitors for the Treatment of CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - April 28, 2009 Category: Pharmaceuticals Source Type: news
Phase III Trial of Nexavar® in Chemotherapy-Naive Patients with Advanced Melanoma Does Not Meet Primary EndpointEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - April 27, 2009 Category: Pharmaceuticals Source Type: news
Bayer CropScience invests EUR 30 million in expansion of crop protection production at the Dormagen Chemical ParkEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Bayer Company News)
Source: Bayer Company News - April 3, 2009 Category: Pharmaceuticals Source Type: news
